All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-20959817

ID	PMID	Mutation	Gene/Protein/Region	Disease	Description	Detail
1	20959817	T1753V	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
2	20959817	C1653T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
3	20959817	T1674C	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
4	20959817	T1674G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
5	20959817	A1762T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
6	20959817	A1726C	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
7	20959817	A1727T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
8	20959817	C1673T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
9	20959817	C1730G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
10	20959817	C1766T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
11	20959817	C1773T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
12	20959817	C1799G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
13	20959817	T1768A	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
14	20959817	G1764A	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
15	20959817	A1846T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
16	20959817	A1703G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
17	20959817	A1727G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	S C L	View
18	20959817	C1913A	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	S C L	View
19	20959817	G1896A	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
20	20959817	T1753A	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
21	20959817	T1753C	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
22	20959817	T1753G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
23	20959817	A1652G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	S C L	View
24	20959817	G1719T	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	G S C L	View
25	20959817	C1727G	Core Promoter	Carcinoma, Hepatocellular Hepatitis B, Chronic Liver Cirrhosis	S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.